Renata Ferrarotto，MD

Ferrarotto博士的作品侧重于检查肺和头部和颈部肿瘤样本的基因和蛋白质谱，以鉴定可以用合适的治疗方案靶向的改变。To accomplish this, alterations of genes and proteins found in tumor samples are correlated with the patient’s individual tumor characteristics and clinical outcomes (disease progression and survival), then the effects of different drugs targeting the gene or protein of interest are examined in cell line and mouse models, and finally the results obtained in the lab are used to develop and design clinical trials with new therapeutic regimens for patients. Currently, Dr. Ferrarotto is leading a project to investigate the importance of Notch1 mutations in patients diagnosed with adenoid cystic carcinoma (ACC), a rare salivary gland tumor. Her work demonstrated that Notch1 mutations in ACC define a subgroup of patients with an aggressive disease and propensity to liver and bone metastasis.

Ferrarotto博士是一名医疗肿瘤科医生，致力于提高患有胸部和颈部恶性肿瘤的患者的患者的品质和长度。她致力于患者护理以及临床和翻译研究。乐动体育LDsports中国Dr. Ferrarotto’s work focuses on identifying predictive biomarkers that can be used to select the patients that will benefit the most from targeted therapy and immunotherapy, particularly in the area of rare cancers (salivary gland cancer, small cell lung cancer, skin cancers, sinonasal cancers, anaplastic thyroid cancer ) that represent a major unmet need. Currently, she directs three clinical trials with targeted therapy and four clinical trials with immunotherapy. In addition, Dr. Ferrarotto is also actively involved in the treatment of oropharyngeal cancers associated with human papillomavirus (HPV) using targeted therapy, immunotherapy, treatment de-intensification and pre-operative systemic therapy.

授予教育

研究生培训